role of non-invasive ventilation in reducing extubation failure in term neonates
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 入组人数
- 105
- 试验地点
- 1
- 主要终点
- To compare the efficacy of nasal CPAP (CPAP), heated humidified high flow nasal cannula (HFNC) and low flow oxygen (LFO) in reducing extubation failure within 72 hours of extubation in term babies.
研究概览
简要总结
Proposal summary
Aim: To study the role of non-invasive ventilation in reducing extubation failures in term neonates
Primary objective: To compare the efficacy of nasal CPAP (CPAP), heated humidified high flow nasal cannula (HFNC) and low flow oxygen (LFO) in reducing extubation failure within 72 hours of extubation in term babies.
Secondary objective: i) to study the profile of term neonates on mechanical ventilation
ii) To study the other secondary outcomes i) need for reintubation, ii) duration of oxygen need, iii) duration of hospital stay and iv) mortality in the three groups
Inclusion criteria: all term babies (gestational age ≥ 37 weeks) on mechanical ventilation when ready for extubation will be included in the study.
Exclusion criteria: i) major congenital malformation ii) genetic syndromes iii) babies who underwent gastrointestinal surgery iv) airway malformations
Term neonates on mechanical ventilation will be randomised when they are ready to be extubated, to receive nasal continuous positive pressure ventilation (CPAP) or heated humidified high flow nasal oxygen (HFNC) or low flow oxygen (LFO) (≤ 1 Lit/m) by prongs immediately after extubation. All babies who were ventilated for ≥ 7 days will be given intravenous dexamethasone in a dose of 0.15 mg/kg/day for 3 doses 8 hours apart starting 2 hours prior to planned extubation. All standard treatment protocols will be followed. Randomization will be done by a computer software into three groups. The allocated group will be placed in a sequentially numbered opaque sealed envelope and will be opened at the time of enrolment.
Extubation failure will be defined as any one of the following in a neonate on maximum support in each group; i) > 3 episodes of apnea (duration ≥ 20 sec) over a period of 1 hour or any episode of apnea needing positive pressure ventilation ii) Silverman Anderson score > 5 iii) neonate not able to maintain saturation 90-95%. Maximum support will be defined as CPAP pressure of 7 cm H2O in CPAP group or flow rate of 7L/min in HFNC group and on flow rate of 1L/min in the LFO group
All babies having extubation failure on HFNC and LFO group will be started on nasal CPAP as a rescue therapy. CPAP failure in these babies will be defined as mentioned earlier. Babies having extubation failure on CPAP will be intubated and stared on mechanical ventilation.
Sample size: Based on the previous studies a sample size of 35 babies will be taken for each group.
All data will be analysed using Epi info 7.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 0.00 Day(s) 至 28.00 Day(s)(—)
- 性别
- All
入选标准
- •all term babies (gestational age ≥ 37 weeks) on mechanical ventilation when ready for extubation will be included in the study.
排除标准
- •i) major congenital malformation ii) genetic syndromes iii) babies who underwent gastrointestinal surgery iv) airway malformations.
结局指标
主要结局
To compare the efficacy of nasal CPAP (CPAP), heated humidified high flow nasal cannula (HFNC) and low flow oxygen (LFO) in reducing extubation failure within 72 hours of extubation in term babies.
时间窗: To compare the efficacy of nasal CPAP (CPAP), heated humidified high flow nasal cannula (HFNC) and low flow oxygen (LFO) in reducing extubation failure within 72 hours of extubation in term babies.
次要结局
- i) to study the profile of term neonates on mechanical ventilation(ii) To study the other secondary outcomes i) need for reintubation, ii) duration of oxygen need, iii) duration of hospital stay & iv) mortality in the three groups)
研究者
Ruchi Rai
Postgraduate Institute of Child Health, Sector 30, Noida
